Covered recipient · General Payments record
BRITTANY A SNIDER
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2019–2024
$697.43
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $295.97 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $78.36 | 5 |
| Merz Pharmaceuticals, LLC | $63.19 | 3 |
| COLOPLAST CORP | $45.27 | 3 |
| Bioventus LLC | $29.19 | 1 |
| C. R. BARD, INC. & SUBSIDIARIES | $18.56 | 1 |
| Azurity Pharmaceuticals, Inc. | $16.15 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $15.85 | 1 |
| Lundbeck LLC | $15.52 | 1 |
| Alexion Pharmaceuticals, Inc. | $13.88 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.42 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106129344 | CMS |
| ABBVIE INC. | $16.10 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106129346 | CMS |
| ABBVIE INC. | $15.20 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106129348 | CMS |
| ABBVIE INC. | $14.05 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106129350 | CMS |
| ABBVIE INC. | $16.59 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106129352 | CMS |
| Alexion Pharmaceuticals, Inc. | $13.88 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093936332 | CMS |
| Azurity Pharmaceuticals, Inc. | $16.15 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134012997 | CMS |
| Bioventus LLC | $29.19 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137449647 | CMS |
| C. R. Bard, Inc. & Subsidiaries | $18.56 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130834850 | CMS |
| COLOPLAST CORP | $16.18 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117432321 | CMS |
| COLOPLAST CORP | $14.09 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117432367 | CMS |
| COLOPLAST CORP | $15.00 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117432549 | CMS |
| Lundbeck LLC | $15.52 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145970952 | CMS |
| Merz Pharmaceuticals, LLC | $24.38 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137947436 | CMS |
| Merz Pharmaceuticals, LLC | $20.32 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137947438 | CMS |
| Merz Pharmaceuticals, LLC | $18.49 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137947440 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $15.85 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105915760 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.